Neither vaginal nor buccal administration of 800 μg misoprostol alters mucosal and systemic immune activation or the cervicovaginal microbiome: a pilot study

References

• Lee OY, Kang DH, Lee DH, et al. A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment. Arch Pharm Res. 2014;37:1308–1316.
   PubMed Web of Science ®Google Scholar
• Sheldon WR, Blum J, Durocher J, Winikoff B. Misoprostol for the prevention and treatment of postpartum hemorrhage. Expert Opin Investig Drugs. 2012;21:235–250.
   PubMed Web of Science ®Google Scholar
• Hofmeyr GJ, Gulmezoglu AM, Pileggi C. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev. 2010;10:CD000941.
   PubMed Web of Science ®Google Scholar
• Chong E, Tsereteli T, Nguyen NN, Winikoff B. A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion. Contraception. 2012;86:251–256.
   PubMed Web of Science ®Google Scholar
• Iyengar S, Contreras PC, Mick SJ, et al. Immune modifying effects of misoprostol and natural prostaglandins. Br J Rheumatol. 1991;30:71–74.
   PubMedGoogle Scholar
• Widomski DL, Walsh RE, Baron DA, et al. Effects of the prostaglandin analogue misoprostol on inflammatory mediator release by human monocytes. Agents Actions. 1991;34:30–31.
   PubMedGoogle Scholar
• Haynes DR, Whitehouse MW, Vernon-Roberts B. The prostaglandin E1 analogue, misoprostol, regulates inflammatory cytokines and immune functions in vitro like the natural prostaglandins E1, E2 and E3. Immunology. 1992;76:251–257.
   PubMed Web of Science ®Google Scholar
• Curtis LD, Anwar N, Briggs JD, et al. Misoprostol in renal transplantation. Transplant Proc. 1993;25:602.
   PubMed Web of Science ®Google Scholar
• Rossetti RG, Seiler CM, Brathwaite K, Zurier RB. Effect of misoprostol on acute and chronic inflammation. Am J Ther. 1995;2:600–606.
   PubMedGoogle Scholar
• Waiser J, Bohler T, Stoll J, et al. The immunosuppressive potential of misoprostol-efficacy and variability. Clin Immunol. 2003;109:288–294.
   PubMed Web of Science ®Google Scholar
• Aronoff DM, Hao Y, Chung J, et al. Misoprostol impairs female reproductive tract innate immunity against Clostridium sordellii. J Immunol. 2008;180:8220–8230.
   Web of Science ®Google Scholar
• Zaslona Z, Okunishi K, Bourdonnay E, et al. Prostaglandin E2 suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells. J Allergy Clin Immunol. 2014;133:379–387.
   PubMed Web of Science ®Google Scholar
• Smallwood JI, Malawista SE. Misoprostol stimulates cAMP generation in human leukocytes: synergy with colchicine suggests a new potential for established drugs. Am J Ther. 1995;2:725–729.
   PubMedGoogle Scholar
• Cheon H, Rho YH, Choi SJ, et al. Prostaglandin E2 augments IL-10 signaling and function. J Immunol. 2006;177:1092–1100.
   PubMed Web of Science ®Google Scholar
• Trussell J, Nucatola D, Fjerstad M, Lichtenberg ES. Reduction in infection-related mortality since modifications in the regimen of medical abortion. Contraception. 2014;89:193–196.
   PubMed Web of Science ®Google Scholar
• Fjerstad M, Trussell J, Sivin I, et al. Rates of serious infection after changes in regimens for medical abortion. N Engl J Med. 2009;361:145–151.
   PubMed Web of Science ®Google Scholar
• Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29:297–301.
   PubMed Web of Science ®Google Scholar
• Iqbal SM, Ball TB, Levinson P, et al. Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition. AIDS. 2009;23:1669–1677.
   PubMed Web of Science ®Google Scholar
• Stock SJ, Duthie L, Tremaine T, et al. Elafin (SKALP/trappin-2/proteinase inhibitor-3) is produced by the cervix in pregnancy and cervicovaginal levels are diminished in bacterial vaginosis. Reprod Sci. 2009;16:1125–1134.
   PubMed Web of Science ®Google Scholar
• Dowd SE, Sun Y, Wolcott RD, et al. Bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP) for microbiome studies: bacterial diversity in the ileum of newly weaned Salmonella-infected pigs. Foodborne Pathog Dis. 2008;5:459–472.
   PubMed Web of Science ®Google Scholar
• Dowd SE, Callaway TR, Wolcott RD, et al. Evaluation of the bacterial diversity in the feces of cattle using 16S rDNA bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP). BMC Microbiol. 2008;8:125.
   PubMed Web of Science ®Google Scholar
• Callaway TR, Dowd SE, Edrington TS, et al. Evaluation of bacterial diversity in the rumen and feces of cattle fed different levels of dried distillers grains plus solubles using bacterial tag-encoded FLX amplicon pyrosequencing. J Anim Sci. 2010;88:3977–3983.
   PubMed Web of Science ®Google Scholar
• Williams WL, Tedeschi LO, Kononoff PJ, et al. Evaluation of in vitro gas production and rumen bacterial populations fermenting corn milling (co)products. J Dairy Sci. 2010;93:4735–4743.
   PubMed Web of Science ®Google Scholar
• DeSantis TZ, Hugenholtz P, Larsen N, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006;72:5069–5072.
   PubMed Web of Science ®Google Scholar
• Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;26:2460–2461.
   PubMed Web of Science ®Google Scholar
• Eren AM, Zozaya M, Taylor CM, et al. Exploring the diversity of Gardnerella vaginalis in the genitourinary tract microbiota of monogamous couples through subtle nucleotide variation. PLoS One. 2011;6:e26732.
   PubMed Web of Science ®Google Scholar
• Swanson KS, Dowd SE, Suchodolski JS, et al. Phylogenetic and gene-centric metagenomics of the canine intestinal microbiome reveals similarities with humans and mice. Isme J. 2011;5:639–649.
   PubMed Web of Science ®Google Scholar
• Moran M, Mozes MF, Maddux MS, et al. Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone. N Engl J Med. 1990;322:1183–1188.
   PubMed Web of Science ®Google Scholar